FSHOX
Price
$127.63
Change
+$0.28 (+0.22%)
Updated
Oct 17 closing price
Net Assets
775.88M
FSRPX
Price
$19.51
Change
+$0.06 (+0.31%)
Updated
Oct 17 closing price
Net Assets
2.66B
Interact to see
Advertisement

FSHOX vs FSRPX

Header iconFSHOX vs FSRPX Comparison
Open Charts FSHOX vs FSRPXBanner chart's image
Fidelity Select Construction & Housing
Price$127.63
Change+$0.28 (+0.22%)
VolumeN/A
Net Assets775.88M
Fidelity Select Retailing
Price$19.51
Change+$0.06 (+0.31%)
VolumeN/A
Net Assets2.66B
FSHOX vs FSRPX Comparison Chart in %
View a ticker or compare two or three
VS
FSHOX vs. FSRPX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSHOX is a Hold and FSRPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSRPX has more cash in the bank: 2.66B vs. FSHOX (776M). FSHOX pays higher dividends than FSRPX: FSHOX (0.64) vs FSRPX (0.12). FSHOX was incepted earlier than FSRPX: FSHOX (39 years) vs FSRPX (40 years). FSHOX (0.69) is less costly to investors than FSRPX (0.64). FSRPX is a more actively managed with annual turnover of: 39.00 vs. FSHOX (36.00). FSHOX (0) and FSRPX (0) have matching initial minimum investment requirements. FSHOX annual gain was more profitable for investors over the last year : -4.20 vs. FSRPX (-5.31). FSHOX return over 5 years is better than : 88.30 vs. FSRPX (-11.10).
FSHOXFSRPXFSHOX / FSRPX
Total Expense Ratio0.690.64108%
Annual Report Gross Expense Ratio0.690.64108%
Fund Existence39 years40 years-
Gain YTD7.225-4.690-154%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/A500-
Net Assets776M2.66B29%
Annual Yield % from dividends0.640.12518%
Returns for 1 year-4.20-5.3179%
Returns for 3 years67.4022.90294%
Returns for 5 years88.30-11.10-795%
Returns for 10 years123.7491.51135%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOFX47.420.61
+1.30%
Patient Opportunity FI
NSBRX66.790.45
+0.68%
Nuveen Dividend Growth I
VTARX11.09N/A
N/A
Virtus Tactical Allocation R6
MISCX19.76-0.07
-0.35%
BNY Mellon Small Cap Multi-Strategy Inv
RHJSX24.15-0.18
-0.74%
Rice Hall James Micro Cap Instl